A diffuse large B-cell lymphoma that is categorized as EZB with high probability by the LymphGen algorithm. This is based on a combination of genetic features and EZB DLBCLs often, but do not always, have hot spot mutations in EZH2 and/or a BCL2 translocation. This class can be further subdivided into two sub-classes EZB-MYC+ and EZB-MYC- using the double hit gene expression signature (DHITsig). This subgroup also commonly has mutations due to aberrant somatic hypermutation affecting IRF8, which can be coding or non-coding.
Comprehensive, easy-to-understand information about this condition
Checking for content...
No external resources available.
relapsed/refractory diffuse large B-cell lymphoma
MONDO:0000901
breast diffuse large B-cell lymphoma
MONDO:0006117
colorectal diffuse large B-cell lymphoma
MONDO:0006158
gastric diffuse large B-cell lymphoma
MONDO:0006223
liver diffuse large B-cell lymphoma
MONDO:0006268
primary cutaneous diffuse large B-cell lymphoma, Leg type
MONDO:0006383